Could cheap water pills protect hearts in early kidney disease?

NCT ID NCT05171686

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This completed study in 49 veterans with early chronic kidney disease (CKD) tested whether diuretics (water pills) can reduce fluid overload and improve heart health. Researchers measured changes in heart stress markers and symptoms like fatigue after 4 weeks of treatment. The goal was to lay groundwork for future studies on whether early use of these inexpensive drugs can prevent heart problems in CKD.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
diuretics (hydrochlorothiazide, chlorthalidone, furosemide, torsemide, bumetanide)
What this could lead to
If successful, this study could show that measuring fluid overload and treating it with diuretics early in kidney disease may improve heart health and symptoms.
What could go wrong
This is a small, early-phase study with only 49 participants, so results may not apply to everyone. It focuses on short-term changes, not long-term outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC KIDNEY DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Michael E. DeBakey VA Medical Center, Houston, TX

    Houston, Texas, 77030-4211, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.